Don’t miss the latest developments in business and finance.

Zydus receives USFDA approval for Bisoprolol Fumarate Tablets

Image
Capital Market
Last Updated : Jul 26 2022 | 6:31 PM IST

Used to treat high blood pressure

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to market Bisoprolol Fumarate Tablets USP 5 mg and 10 mg. USRLD: Zebeta.

Bisoprolol Fumarate Tablets are used to treat high blood pressure. They can be used alone or in combination with other high blood pressure medications to lower blood pressure. The drug will be manufactured at the group's formulation manufacturing facility at, SEZ, Ahmedabad, India and will be distributed by Viona Pharmaceuticals Inc.

Bisoprolol Fumarate Tablets had annual sales of USD 30 million in the United States according to IQVIA data.

Powered by Capital Market - Live News

Also Read

First Published: Jul 26 2022 | 6:16 PM IST

Next Story